RecruitingNCT05850273

Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms

Studying Myeloproliferative neoplasm

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Principal Investigator
Florence Pasquier, MD,PhD
florence.pasquier@gustaveroussy.fr
Enrollment
80 target
Eligibility
18 years · All sexes
Timeline
2023 – 2033

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05850273 on ClinicalTrials.gov

Other trials for Myeloproliferative neoplasm

Additional recruiting or active studies for the same condition.

See all trials for Myeloproliferative neoplasm →

← Back to all trials